About us

Transmural Biotech is a spin-off of the Hospital Clinic of Barcelona and the University of Barcelona created at the end of 2009 by medical and engineering professionals.

Our expertise focuses on developing innovative medical technologies, based on image analysis and processing, to provide health professionals with additional information that current technologies cannot provide and substantially improve the quality of service they can offer the patient.

In 2019, we received three prestigious awards in the biotech field: we were selected as one of the 20 most innovative medtech companies according to “Technology Innovators”, we were ranked as one of the 50 top digital companies in the world according to “The Silicon Review” and we received the Most Promising Digital Medicine Innovation award from NODE.Health. Before winning these awards, PWC valued the company at 68 million euros.

About us

Transmural Biotech is a spin-off of the Hospital Clinic of Barcelona and the University of Barcelona created at the end of 2009 by medical and engineering professionals.

Our expertise focuses on developing innovative medical technologies, based on image analysis and processing, to provide health professionals with additional information that current technologies cannot provide and substantially improve the quality of service they can offer the patient.

In 2019, we received three outstanding awards in the field of biotechnology: we entered the ranking of the 20 most innovative companies in the world according to «Technology Innovators», we are one of the most relevant digital companies according to «The Silicon Review» and we received the award to the most promising Innovation in Digital Medicine granted by NODE.Health. Before the achievement of these awards, PWC valued the company at 68 million euros.

Our mission

Transmural Biotech develops innovative products and services in the clinical field through image analysis technologies that allow personalized, economical, non-invasive and efficient medicine.

Leaders – We are one of the 20 most important MedTech companies in the world.

Vanguard – We develop medical technologies based on image diagnosis through artificial intelligence. Two basic platforms: image-based AI and algorithms as a predictive basis for medical diagnosis.

Commited to medicine – We are committed to a personalized, predictive, non-invasive, rapid and reliable clinical diagnosis.

International soul – We are commited to a global distribution.

Our vision

We have a total commitment to the excellence in research and development and we belief to an ethical commercialization of medical technologies that allow us to substantially improve the care that patients receive.

Technological

We specialize in analysis and image processing through Artificial Intelligence. All our projects have their own coordination, planning and consulting.

Clinic

We develop diagnostic technologies to improve clinical care for patients. We have international reference clinical prescribers such as BCNATAL.

Business

Business models identification and development based on new technologies such as the Internet to maximize its use, accessibility and competitiveness of our products.

Transversal

Our solutions are applicable in different medicine fields, improving the diagnosis of maternal-fetal, oncological, neurodegenerative or cardiovascular pathologies.

Global distribution

quantusFLM is present in countries on most continents of the planet, Latin America, North America, Europe and Asia. A distribution agreement has been signed in China and a substantial part of Asia, which will report a minimum of 6 million annual tests in 2023, and more than half a million already in 2020.

Meet our management team

Dr. Benito García-Legaz
Dr. Benito García-LegazChairman
Medical Specialist and Health Systems Manager
Medical Director of the first hospital group in Spanish capital, the HLA holding, owned by Asisa. HLA is composed of 15 hospitals, 32 specialized medical centers and more than 3000 professionals. National Health&Computers Award 2018.
Miguel Ángel Lorente
Miguel Ángel LorenteChief Executive Officer
Economist
23 years as General Management in the two main Spanish banking groups -with a very wide international expansion-; 10 years developing strategic consulting in the health sector.
Dr. Carlos Hugo Martínez
Dr. Carlos Hugo MartínezMember of the Board
Doctor and Researcher in Morphological Sciences, with outstanding cum laude. Licensed in medicine
Among the worldwide elite of maxillofacial specialists and a member of the most prestigious international societies in this area. Scientific collaborator of the Faculty of Medicine of the Complutense University of Madrid. Asisa manager.
David Fernández
David FernándezHead of Transmural Biotech
Eng. in Computer Science (NCR)
More than 17 years developing computer system integrations on internet technologies and mobile platforms.
Yalu Liu
Yalu LiuInternational Director
Businesswoman and Graduate in Translation and Interpretation
Specialized in representation of European companies in Asia, with studies in China, Canada, France and Spain. One of the main architects of the Quantus distribution agreement in China and much of Asia.
Ángela Iriarte
Ángela IriarteBusiness Development Director
Economist
With extensive experience in business development in Latin America and European companies in the region. Architect of the Quantus distribution agreements in Latin American countries and with ultrasound manufacturers.
Silvia Sánchez
Silvia SánchezOrganization Director
Master in Public Administration (MPA)
More than 15 years of international experience (USA, UK, Spain) in development, team management and administrative processes efficiency.
Àlvaro Pérez-Moreno
Àlvaro Pérez-MorenoChief Technical Officer
B.Eng in Telecommunications (UPC) and Ph.D in BioMedicine (UB, KU Leuven, LUND)
More than 10 years developing and transferring medical technologies based on image diagnosis.
Xavier P. Burgos-Artizzu
Xavier P. Burgos-ArtizzuChief Scientific Officer
B.Eng. in Computer Science and Ph.D. in Artificial Intelligence (UCM)
More than 12 years developing AI methods for varied applications with several scientific publications and industrial patents.
Carlos López
Carlos LópezIT Technical Director
Eng. in Computer Science (UDC)
More than 20 years developing and managing IT solutions in various technologies (Internet, mobile devices, host services, SAP, IBM, banking solutions, …)
Mara Domínguez
Mara DomínguezService Manager
Eng in Telecommunications (UC), MSc in Telemedicine and Bioengineering (UPM).
More than 6 years developing medical technologies and managing web applications and client support area.
David Coronado
David CoronadoResearch Project Manager
B. Eng. in Telecommunications (UPC) and MSc in Biomedical Engineering (UB).
More than 5 years developing medical technologies based on image diagnosis and AI.

Eduard Gratacós
Eduard GratacósScientific Reference
Doctor, Professor and Researcher
Among the most prestigious specialists in maternal and fetal medicine in the world, with thousands of interventions in fetuses. Professor of Gynecology at the University of Barcelona. Director of BCNatal, one of the first three international reference research centers, whose annual activity reports, yearly published online, impress with their ongoing projects. Transmural Biotech has a collaboration agreement established with BCNatal, where our company’s researchers are located.
Montse Palacio
Montse PalacioScientific Advisor
Doctor, Professor and Researcher
An international authority in studies on prematurity. She directs important research at BCNatal on fetal problems (in addition to those of Quantus products) and their influence on the future of neonates. She has participated in the medical dissemination of the Quantus protocols in six countries.

“No call pending”

Contact us